6 commercial payer policies list C88.0. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
6 policies from 3 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of C88.0 |
|---|---|---|
| Hematopoietic Cell Transplantation for Multiple Myeloma | Dec 13, 2023 | Covered |
| Immune Globulins for Post-Exposure Prophylaxis | Sep 21, 2023 | Covered |
| Tumor Markers | Mar 5, 2024 | Covered |
| Policy | Effective | Status of C88.0 |
|---|---|---|
| Donor Lymphocyte Infusion for Hematologic Malignancies after Allogeneic Hematopoietic Progenitor Cell Transplantation | Jul 1, 2026 | Covered |
| Therapeutic Apheresis | Apr 15, 2026 | Covered |
| Policy | Effective | Status of C88.0 |
|---|---|---|
| Pulmonary Function Testing | Not recorded | Covered |